Richard Knochenmuss

Title: Richard Knochenmuss: Innovator in Medical Modulation

Introduction

Richard Knochenmuss is a notable inventor based in Birmensdorf, Switzerland. He has made significant contributions to the field of medical research, particularly in the modulation of viral interactions. His work focuses on the Epstein-Barr virus and its associated receptors, which are crucial in understanding various medical conditions.

Latest Patents

Knochenmuss holds a patent titled "Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands." This invention relates to modulators that affect the interaction between Epstein-Barr Virus induced receptor-2 (EBi2) and specific cholesterol derivatives. The modulator can be a small chemical molecule, an antibody, or another therapeutic protein. Additionally, the patent describes methods for medical treatment and identifying these modulators.

Career Highlights

Throughout his career, Richard Knochenmuss has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Novartis AG and Irm LLC. His experience in these organizations has contributed to his expertise in medical modulation and therapeutic development.

Collaborations

Knochenmuss has collaborated with several professionals in his field, including Birgit Uta Baumgarten and Francois Gessier. These collaborations have enhanced his research and innovation efforts, leading to advancements in medical treatments.

Conclusion

Richard Knochenmuss is a distinguished inventor whose work in medical modulation has the potential to impact therapeutic approaches significantly. His patent and collaborations reflect his commitment to advancing medical science.